Howton David T 4
4 · Solid Biosciences Inc. · Filed Feb 6, 2026
Research Summary
AI-generated summary of this filing
Solid Biosciences (SLDB) COO David Howton Sells 18,894 Shares
What Happened
- David T. Howton, Chief Operating Officer of Solid Biosciences (SLDB), disposed of 18,894 shares on 2026-02-04 via an open‑market sale. The weighted average sale price was $6.44 per share (sales ranged from $6.28 to $6.60), for total gross proceeds of about $121,713. This was a sale, not a purchase.
Key Details
- Transaction date: 2026-02-04; Form 4 filed: 2026-02-06 (timely filing).
- Shares sold: 18,894; weighted average price: $6.44; price range: $6.28–$6.60.
- Total proceeds: ~$121,713.
- Shares owned after transaction: not disclosed in the provided excerpt of the filing.
- Footnote F1: Sale was executed under a durable automatic sell‑to‑cover instruction to satisfy withholding taxes following RSU vesting and was not a discretionary trade by Mr. Howton.
- Footnote F2: Reported price is a weighted average; the filer can provide a breakdown of shares sold at each price upon request.
Context
- This was a routine sell‑to‑cover to meet tax withholding obligations after restricted stock units vested; such transactions are common and generally not interpreted as an independent signal of the insider’s view on the company’s stock.
- No option exercises, gifts, or 10% owner transactions are involved here.
Insider Transaction Report
Form 4
Howton David T
Chief Operating Officer
Transactions
- Sale
Common Stock
[F1][F2]2026-02-04$6.44/sh−18,894$121,713→ 97,859 total
Footnotes (2)
- [F1]This sale was made to cover withholding taxes following the vesting of previously granted restricted stock units pursuant to a durable automatic sale instruction letter adopted by Mr. Howton on August 16, 2024 effecting the sell-to-cover election. The sale does not represent a discretionary trade by Mr. Howton.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.28 to $6.60, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form.
Signature
/s/ Kimberly Cornwell as attorney-in-fact for David Tyronne Howton|2026-02-06